Studies have shown that Deregulation of the mammalian TOR (mTOR) signaling network is associated with cancer, because MTOR is activated in a variety of cellular processes, such as tumorigenesis, angiogenesis, and lymphocyte activation, and is dysregulated in a variety of cancers [46–48]. This evidence concerns the gene MTOR and cancer.